Health impact from frequent and continuous glucose monitoring

Diabetes Technology and Therapeutics

Volumn 6, Issue 4, 2004, Pages 523-524

  Garg, Satish K ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

BLOOD GLUCOSE MONITORING; DIABETES CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GLYCEMIC INDEX; HUMAN; HYPOGLYCEMIA; INTERMETHOD COMPARISON; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; RETROSPECTIVE STUDY; RISK REDUCTION;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIA; MONITORING, AMBULATORY; REPRODUCIBILITY OF RESULTS;

EID: 4344625752     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/1520915041706009     Document Type: Note

References (4)

1. Tavris DR, Shoaibi A: The public health impact of the MiniMed Continuous Glucose Monitoring System (CGMS®)-an assessment of the literature. Diabetes Technol Ther 2004;6:518-522.
2. Fiallo-Scharer R, Xing D, Weinzimer SA, et al.: Utility of CGMS as a measure of glycemic control in children with type 1 diabetes. Diabetes 2004;53(Suppl 2):A67.
3. The Diabetes Research in Children Network (DirecNet) Study Group: The accuracy of the GlucoWatch® G2™ Biographer in children with Type 1 diabetes: results of the Diabetes Research in Children Network (DirecNet) accuracy study. Diabetes Technol Ther 2003;5:791-800.
4. Garg SK, Schwartz S, Edelman SV: Improved glucose excursions using an implantable real-time continuous implanted glucose sensor in adults with type 1 diabetes. Diabetes Care 2004;27:734-738.